ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ngµç×ÓÓÎÏ·ÍŶÓÌá³ö¸´·¢×ªÒƱÇÑʰ©ÖÎÁÆÐ·½°¸

¸å¼þȪԴ£º£ºÖ×Áö·ÀÖÎÖÐÐÄ ±à¼­£º£ºÌ¸Ï£¡¢Íõ¶¬Ã· ÉóºË£º£ºËïÒ«±ó ÔĶÁÁ¿£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÕÔÏÖÍ¢£©2023Äê11ÔÂ28ÈÕ£¬£¬ £¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÐìÈ𻪽ÌÊÚǣͷ¿ªÕ¹µÄIIIÆÚJUPITER-02Ñо¿×îÖÕЧ¹ûÓÚ¹ú¼Ê¶¥¼âȨÍþÆÚ¿¯¡¶ÃÀ¹úҽѧ»áÔÓÖ¾¡·£¨Journal of the American Medical Association, JAMA£©ÔÚÏß½ÒÏþ¡£¡£¡£

×÷Ϊ±ÇÑʰ©ÃâÒßÖÎÁÆÁìÓòÊ׸ö¹ú¼Ê¶àÖÐÐÄ¡¢Ñù±¾Á¿×î´óµÄ˫ä¡¢Ëæ»ú±ÈÕÕIIIÆÚÁÙ´²Ñо¿£¬£¬ £¬JUPITER-02Ñо¿Ð§¹û¶à´ÎÁÁÏà°üÀ¨ASCOÈ«Ìå´ó»áÖ÷Ìâ½²»°µÈ¹ú¼ÊѧÊõ´ó»á£¬£¬ £¬²¢³ÉΪÈٵǹú¼ÊȨÍþҽѧÔÓÖ¾¡¶×ÔÈ»-ҽѧ¡·£¨Nature Medicine£©Í¬Ê±»ñÔÓÖ¾·âÃæÍÆ¼öµÄÖйúÁ¢ÒìÒ©Ñо¿¡£¡£¡£´Ë´ÎJUPITER-02Ñо¿Ô¤Éè×ÜÉúÑÄÆÊÎöЧ¹û£¨3ÄêÉúÑÄËæ·Ã£©½ÒÏþÔÚSCIÓ°ÏìÒò×ÓÅÅÃûTOP 4µÄ¹ú¼Ê¶¥¼âÆÚ¿¯ÉÏ£¬£¬ £¬³ÉΪ±ÇÑʰ©ÃâÒßÖÎÁÆÁìÓòÈ«ÇòÊ׸öÈÙµÇJAMAÖ÷¿¯µÄÁÙ´²Ñо¿£¬£¬ £¬ÔÙ¶ÈÕÃÏÔÁË¡°ÖйúѧÕß+±¾ÍÁÐÂÒ©¡±×éºÏµÄÇ¿¾¢ÊµÁ¦ºÍ¹ú¼ÊѧÊõ½ç¶Ô¹ú²úÁ¢ÒìÃâÒßÒ©ÎïµÄÈϿɡ£¡£¡£

±¾ÎĵÄÅäºÏͨѶ×÷ÕßÊÇngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÐìÈ𻪽ÌÊÚºÍÂóº£Ç¿½ÌÊÚ£¬£¬ £¬ÅäºÏµÚÒ»×÷ÕßÊÇngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÂóº£Ç¿½ÌÊںͳÂÇïÑà½ÌÊÚ¡£¡£¡£

JUPITER-02ÊÇÒ»ÏîÔÚÖС¢ÃÀÁ½µØ×¢²áµÄ¹ú¼Ê¶àÖÐÐÄ¡¢Ëæ»ú˫䡢ο½å¼Á±ÈÕÕIIIÆÚÁÙ´²Ñо¿¡£¡£¡£Ñо¿×Ô2018Äê11ÔÂÖÁ2019Äê10Ô£¬£¬ £¬ÔÚ35ÆäÖÐÐĹ²Èë×é289Àý¼ÈÍùδ½ÓÊÜϵͳÖÎÁƵĸ´·¢×ªÒƱÇÑʰ©£¨RM-NPC£©»¼Õߣ¬£¬ £¬Ëæ»ú£¨1:1£©½ÓÊÜÌØÈðÆÕÀûµ¥¿¹240mg£¨n=146£©»òο½å¼Á£¨n=143£©ÁªºÏ¼ªÎ÷Ëû±õ+˳²¬£¨GP£©»¯ÁÆ£¨×î¶à6ÖÜÆÚ£©£¬£¬ £¬Ëæºó½ÓÊÜÌØÈðÆÕÀûµ¥¿¹»òο½å¼Áµ¥Ò©ÖÎÁÆ¡£¡£¡£Ö÷ÒªÖÕµãΪƾ֤RECIST v1.1±ê×¼ÆÀ¹ÀµÄÎÞÏ£ÍûÉúÑÄÆÚ£¨PFS£©£¬£¬ £¬´ÎÒªÖÕµã°üÀ¨×ÜÉúÑÄÆÚ£¨OS£©¡¢¿Í¹Û»º½âÂÊ£¨ORR£©¡¢»º½â³ÖÐøÊ±¼ä£¨DoR£©ºÍÇå¾²ÐԵȡ£¡£¡£

¸ÃÑо¿¶Ô¸´·¢×ªÒƱÇÑʰ©»¼ÕßÓÐʲô»ñÒæ£¿

1.½«éæÃü·çÏÕ½µµÍ37%£¬£¬ £¬Îª¸´·¢×ªÒƱÇÑʰ©»¼Õß´øÀ´ÓÀÉúÑÄÊï¹â¡£¡£¡£

×èÖ¹2022Äê11ÔÂ18ÈÕ£¬£¬ £¬ÖÐλÉúÑÄËæ·Ã36.0¸öÔ£¬£¬ £¬ÆÊÎöЧ¹ûÏÔʾ£¬£¬ £¬Óë´¿´â»¯ÁÆÏà±È£¬£¬ £¬±¾·½°¸¿ÉÏÔÖøÑÓÓÀÉúÑÄÆÚ£¬£¬ £¬ÖÐλÉúÑÄÆÚΪÉÐδµÖ´ï£¬£¬ £¬±ÈÕÕ»¯ÁÆ×éµÄ33.7¸öÔ£¬£¬ £¬éæÃü·çÏÕ½µµÍ37%£¬£¬ £¬HR=0.63£¨95% CI£º£º0.45-0.89£©£¬£¬ £¬Ë«²àP=0.008¡£¡£¡£1Äê¡¢2ÄêºÍ3ÄêOSÂÊ»®·ÖΪ90.9% vs. 87.1%¡¢78.0% vs. 65.1%ºÍ64.5% vs. 49.2%¡£¡£¡£

Ö÷ÒªÑÇ×éÆÊÎöÏÔʾ£¬£¬ £¬ÎÞÂÛPD-L1±í´ï״̬»òEBV DNAˮƽÔõÑù£¬£¬ £¬±¾×éºÏ·½°¸¾ù¾ßÓиüÓŵÄÉúÑÄ»ñÒæ¡£¡£¡£

F7B2FCE38ED6A080BA9A2C983C5_72C91851_819A

×îÖÕ×ÜÉúÑÄÆÚÆÊÎö

2.ÖÐλÎÞÏ£ÍûÉúÑÄÆÚÑÓÉì¿¿½ü3±¶£¬£¬ £¬»¼Õß»ñÒæÏÔ×Å¡£¡£¡£

×èÖ¹2021Äê6ÔÂ8ÈÕ£¬£¬ £¬×îÖÕÎÞÏ£ÍûÉúÑÄÆÚÆÊÎöÏÔʾ£¬£¬ £¬ÌØÈðÆÕÀûµ¥¿¹ÁªºÏGP»¯ÁÆ×éÖÐλÎÞÏ£ÍûÉúÑÄÆÚ±ÈÕÕ´¿´â»¯ÁÆÑÓÉìÁË13.2¸öÔ£¬£¬ £¬¿¿½ü3±¶£¨Á½×éÖÐλPFS»®·ÖΪ21.4 vs. 8.2¸öÔ£©£¬£¬ £¬HR=0.52 (95%CI£º£º0.37-0.73£©¡£¡£¡£1ÄêºÍ2ÄêPFSÂÊ»®·ÖΪ59.0% vs. 32.9% ºÍ44.8% vs. 25.4%¡£¡£¡£Ñо¿Õ߯À¹ÀµÄPFSÒ²ÏÔʾÁËÏàËÆµÄЧ¹û¡£¡£¡£

Ö÷ÒªÑÇ×éÆÊÎöÏÔʾ£¬£¬ £¬ËùÓÐÒªº¦ÑÇ×é¾ùÊÓ²ìµ½ÌØÈðÆÕÀûµ¥¿¹ÁªºÏ»¯ÁÆ×éµÄPFS¸üÓÅ¡£¡£¡£

2D4FE62F578AE72F895A79A33C0_84DE07A5_741A

×îÖÕÎÞÏ£ÍûÉúÑÄÆÚÆÊÎö

3.ʵÏÖ¸ü¸ßµÄÍêÈ«»º½âÂÊ£¬£¬ £¬²¢»ñµÃ¸ü³¤ÆÚµÄ»º½âʱ¼ä¡£¡£¡£

×èÖ¹2021Äê6ÔÂ8ÈÕ£¬£¬ £¬ÌØÈðÆÕÀûµ¥¿¹ÁªºÏ»¯ÁÆ×é½Ïο½å¼ÁÁªºÏ»¯ÁÆ×éµÄ¿Í¹Û»º½âÂÊÓÐËùÌáÉý£¬£¬ £¬»®·ÖΪ78.8% vs. 67.1% £»£»ÓÈÆäÊÇ£¬£¬ £¬ÌØÈðÆÕÀûµ¥¿¹×éµÄÍêÈ«»º½âÂÊÊÇ´¿´â»¯ÁƵÄ2±¶(26.7% vs. 13.3%)¡£¡£¡£

ÌØÈðÆÕÀûµ¥¿¹ÁªºÏ»¯ÁÆ×éÖÐλ»º½â³ÖÐøÊ±¼äÊÇ»¯ÁÆ×éµÄ3±¶£¬£¬ £¬»ñµÃ¸ü³¤ÆÚµÄ»º½â¡£¡£¡£Á½×éµÄÖÐλ»º½â³ÖÐøÊ±¼ä»®·ÖΪ18.0 vs. 6.0¸öÔ£¬£¬ £¬HR=0.49£¨95% CI: 0.33-0.72)¡£¡£¡£

4.ʵÏÖ¸ü¿ìµÄEBV DNA¿½±´ÊýϽµ£¬£¬ £¬ÇÒ²»Ò×·´µ¯¡£¡£¡£

EB²¡¶¾£¨EBV£©Ç±ÔÚѬȾÊDZÇÑʰ©·¢²¡µÄÖ÷ÒªÔ­Òò£¬£¬ £¬Ñо¿Ö°Ô±Í¨¹ý¶¯Ì¬¼à²âѪ½¬EBV DNA¿½±´Êý̽Ë÷ÁËÆäÓëÁÙ´²ÁÆÐ§µÄÏà¹ØÐÔ¡£¡£¡£Ñо¿·¢Ã÷£¬£¬ £¬Á½×黼ÕßÔÚ½ÓÊÜÖÎÁƺ󣬣¬ £¬EBV DNA¿½±´ÊýïÔÌ­£¬£¬ £¬ÆäÖÐÌØÈðÆÕÀûµ¥¿¹×éÓÐ96.3%µÄ»¼ÕßEBV DNA¿½±´ÊýϽµµ½ÎÞ·¨¼ì²âµ½µÄˮƽ¡£¡£¡£ÔÚ³õʼϽµºó£¬£¬ £¬ÌØÈðÆÕÀûµ¥¿¹×黼Õß·ºÆðEBV DNA¿½±´Êý·´µ¯µÄ±ÈÀýÏÔ×ŵÍÓÚ´¿´â»¯ÁÆ×飨36.5% vs. 57.4%£©£¬£¬ £¬ÇÒÌØÈðÆÕÀûµ¥¿¹×黼Õ߸üÍí±¬·¢EBV DNA¿½±´Êý·´µ¯£¬£¬ £¬Á½×é´Ó×îµÍEBV DNA¿½±´Êýµ½·´µ¯µÄÖÐλʱ¼ä»®·ÖΪ20.5 vs. 6.0¸öÔ¡£¡£¡£

JAMAÔÓÖ¾»¹¾Í¸ÃÑо¿½ÒÏþÁËÉçÆÀ£º£ºÔÚÒÑÍù¼¸ÄêÖУ¬£¬ £¬JUPITER-02¼°ÁíÍâ 2 ÏîIIIÆÚÊÔÑé֤ʵÎúÔÚ¸´·¢/×ªÒÆÐÔ±ÇÑʰ©µÄGP»¯ÁÆÁªºÏPD-1ÒÖÖÆ¼Á£¬£¬ £¬¿ÉÒÔÏÔÖøÑÓÉ컼ÕßÎÞÏ£ÍûÉúÑÄÆÚ¡£¡£¡£µ«µ½ÏÖÔÚΪֹ£¬£¬ £¬Ö»ÓÐJUPITER-02±¨¸æÁËÓÐÀûÓÚÃâÒßÖÎÁÆÁªºÏ×éµÄ³ÉÊìÇÒÏÔÖøµÄ×ÜÉúÑÄÆÚÊý¾Ý¡£¡£¡£

2023Äê10Ô£¬£¬ £¬×÷ΪÖйúÊ׸ö×ÔÖ÷Ñз¢ºÍÉú²úµÄÁ¢ÒìÉúÎïÒ©£¬£¬ £¬ÌØÈðÆÕÀûµ¥¿¹»ñÃÀ¹úʳÎïÒ©Æ·¼àÊÓÖÎÀí¾Ö£¨FDA£©Åú×¼ÉÏÊУ¬£¬ £¬ÓÃÓÚ¸´·¢×ªÒƱÇÑʰ©µÄÈ«ÏßÖÎÁÆ£¬£¬ £¬ÕâÒ²ÊÇÃÀ¹úÊ׸öÇÒΨһ»ñÅúÓÃÓÚ±ÇÑʰ©ÖÎÁƵÄÒ©Îï¡£¡£¡£±ðµÄ£¬£¬ £¬¸ÃÁÙ´²Ñо¿Ð§¹ûÓÐÍûÍÆ¶¯Ò©Îïͨ¹ýÅ·ÖÞÒ©Æ·ÖÎÀí¾Ö£¨EMA£©ºÍÓ¢¹úÒ©Æ·ºÍ±£½¡Æ·ÖÎÀí¾Ö£¨MHRA£©ÉóÅú£¬£¬ £¬ÔÚÅ·ÖÞÒÔ¼°¸ü¶àµÄ¹ú¼ÒºÍµØÇøÉÏÊУ¬£¬ £¬Ô츣ȫÇò»¼Õß¡£¡£¡£

¸ÃÑо¿ÊÇÈ«ÇòÊ׸ö±ÇÑʰ©Ò»ÏßÃâÒßÁªºÏ»¯ÁƱÈÕÕ´¿´â»¯ÁÆÓÐͳ¼ÆÑ§²î±ðµÄÉúÑÄ»ñÒæµÄIIIÆÚÁÙ´²Ñо¿£¬£¬ £¬ÎªÌØÈðÆÕÀûµ¥¿¹ÁªºÏ»¯ÁƳÉΪеıÇÑʰ©Ò»Ïß±ê×¼ÖÎÁÆÌṩÁËÈ·ÔäÖ¤¾Ý£¬£¬ £¬ÕÃÏÔÁËÖйúѧÕßÔÚÖ×ÁöÃâÒßÖÎÁÆÁÙ´²Ñо¿ÁìÓòµÄÒýÁìְλ¡£¡£¡£

ÂÛÎÄÁ´½Ó£º£ºhttps://jamanetwork.com/journals/jama/article-abstract/2812324

¡¾ÍøÕ¾µØÍ¼¡¿